Literature DB >> 18253045

Eosinophilic esophagitis and Barrett's esophagus: an occasional association or an overlap disease? Esophageal 'double trouble' in two children.

Paola Francalanci1, Paola De Angelis, Francesca Minnei, Francesca Diomedi Camassei, Filippo Torroni, Luigi Dall'Oglio, Francesco Callea.   

Abstract

BACKGROUND: Esophageal diseases are common in infants and children, and may present with several clinical and pathological aspects. Eosinophilic esophagitis (EE) is characterized by inflammatory, predominantly eosinophilic infiltrate (> or =15 eosinophils per high-power field (HPF)) that is not responsive to acid suppression therapy. An immunoallergic pathogenesis has been hypothesized, likely related to food allergy. Barrett's esophagus (BE) is due to chronic gastroesophageal reflux. The pathological consequence is the replacement of normal stratified squamous epithelium by columnar mucosa with goblet cells.
METHODS: We present 2 children with a history of food allergy. Endoscopy revealed linear furrows and yellow plaques in the mid-distal esophagus.
RESULTS: In both patients histology showed a high number of eosinophils (>30 at HPF) in the mid-distal esophagus and intestinal metaplasia with goblet cells in distal esophagus. Diagnosis of EE associated to BE was made. Restriction diet was administered to treat EE whereas, in 1 case, laparoscopic fundoplication was performed to treat BE. Follow-up showed a remission of endoscopic and histological aspects.
CONCLUSIONS: The unusual, possibly fortuitous association of EE and BE, two conditions differing in etiopathogenesis, clinical and pathological features, calls for a correct diagnosis to offer suitable treatment and prognosis. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18253045     DOI: 10.1159/000114828

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  8 in total

Review 1.  Guidelines for surgical treatment of gastroesophageal reflux disease.

Authors:  Dimitrios Stefanidis; William W Hope; Geoffrey P Kohn; Patrick R Reardon; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

Review 2.  Eosinophilic esophagitis.

Authors:  Fouad J Moawad; Ganesh R Veerappan; Roy K Wong
Journal:  Dig Dis Sci       Date:  2009-06-25       Impact factor: 3.199

3.  Barrett's esophagus is negatively associated with eosinophilic esophagitis in Japanese subjects.

Authors:  Shingo Takashima; Fumio Tanaka; Koji Otani; Shuhei Hosomi; Yasuaki Nagami; Noriko Kamata; Koichi Taira; Hirokazu Yamagami; Tetsuya Tanigawa; Shinya Fukumoto; Toshio Watanabe; Yasuhiro Fujiwara
Journal:  Esophagus       Date:  2018-10-16       Impact factor: 4.230

4.  Prevalence of esophageal eosinophilia and eosinophilic esophagitis in adults: a population-based endoscopic study in Shanghai, China.

Authors:  Xiuqiang Ma; Qin Xu; Yanling Zheng; Yanfang Zhao; Jian Lu; Rui Wang; Zhaoshen Li; Duowu Zou; Jia He
Journal:  Dig Dis Sci       Date:  2015-01-20       Impact factor: 3.199

5.  Molecules involved in the development of Barrett's esophagus phenotype in chronic eosinophilic esophagitis.

Authors:  Sathisha Upparahalli Venkateshaiah; Chandra Sekhar Yadavalli; Hemanth Kumar Kandikattu; Sandeep Kumar; Lokanatha Oruganti; Anil Mishra
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-04-19       Impact factor: 4.871

Review 6.  Eosinophilic esophagitis: the newest esophageal inflammatory disease.

Authors:  Dan Atkins; Robert Kramer; Kelley Capocelli; Mark Lovell; Glenn T Furuta
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

Review 7.  Eosinophilic esophagitis: an immune-mediated esophageal disease.

Authors:  Jenny Weinbrand-Goichberg; Idit Segal; Adi Ovadia; Arie Levine; Ilan Dalal
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

8.  Barrett's esophagus in children: what is the evidence?

Authors:  Maja Raicevic; Amulya K Saxena
Journal:  World J Pediatr       Date:  2018-07-10       Impact factor: 2.764

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.